|
1
|
Generation of functional human hepatic endoderm from human induced pluripotent stem cells.
|
Hepatology
|
2010
|
3.36
|
|
2
|
Lineage-specific distribution of high levels of genomic 5-hydroxymethylcytosine in mammalian development.
|
Cell Res
|
2011
|
1.76
|
|
3
|
Progress and future challenges in stem cell-derived liver technologies.
|
Am J Physiol Gastrointest Liver Physiol
|
2009
|
1.32
|
|
4
|
Developing high-fidelity hepatotoxicity models from pluripotent stem cells.
|
Stem Cells Transl Med
|
2013
|
1.27
|
|
5
|
Post-translational modification by SUMO.
|
Toxicology
|
2010
|
1.26
|
|
6
|
Persistence of functional hepatocyte-like cells in immune-compromised mice.
|
Liver Int
|
2010
|
1.18
|
|
7
|
Pluripotent stem cell-derived hepatocytes: potential and challenges in pharmacology.
|
Annu Rev Pharmacol Toxicol
|
2013
|
1.10
|
|
8
|
The inhibitory role of stromal cell mesenchyme on human embryonic stem cell hepatocyte differentiation is overcome by Wnt3a treatment.
|
Cloning Stem Cells
|
2008
|
1.09
|
|
9
|
The comparison between conditioned media and serum-free media in human embryonic stem cell culture and differentiation.
|
Cell Reprogram
|
2010
|
1.08
|
|
10
|
Accurate prediction of drug-induced liver injury using stem cell-derived populations.
|
Stem Cells Transl Med
|
2013
|
1.07
|
|
11
|
Cadaveric hepatocytes repopulate diseased livers: life after death.
|
Gastroenterology
|
2010
|
1.05
|
|
12
|
SUMOylation of HNF4α regulates protein stability and hepatocyte function.
|
J Cell Sci
|
2012
|
1.01
|
|
13
|
Deriving functional hepatocytes from pluripotent stem cells.
|
Curr Protoc Stem Cell Biol
|
2014
|
0.99
|
|
14
|
Pluripotent stem cell derived hepatocyte like cells and their potential in toxicity screening.
|
Toxicology
|
2010
|
0.99
|
|
15
|
Progenitor cell characterization and location in the developing human liver.
|
Stem Cells Dev
|
2007
|
0.91
|
|
16
|
Liver tissue engineering and cell sources: issues and challenges.
|
Liver Int
|
2013
|
0.91
|
|
17
|
Robust generation of hepatocyte-like cells from human embryonic stem cell populations.
|
J Vis Exp
|
2011
|
0.87
|
|
18
|
Role of stem-cell-derived hepatic endoderm in human drug discovery.
|
Biochem Soc Trans
|
2010
|
0.84
|
|
19
|
Development of an embryoid body-based screening strategy for assessing the hepatocyte differentiation potential of human embryonic stem cells following single-cell dissociation.
|
Cell Reprogram
|
2013
|
0.83
|
|
20
|
A genome-wide screen in human embryonic stem cells reveals novel sites of allele-specific histone modification associated with known disease loci.
|
Epigenetics Chromatin
|
2012
|
0.83
|
|
21
|
Three-dimensional culture of human embryonic stem cell derived hepatic endoderm and its role in bioartificial liver construction.
|
J Biomed Biotechnol
|
2010
|
0.83
|
|
22
|
Maternal Smoking Dysregulates Protein Expression in Second Trimester Human Fetal Livers in a Sex-Specific Manner.
|
J Clin Endocrinol Metab
|
2015
|
0.82
|
|
23
|
Hepatic endoderm differentiation from human embryonic stem cells.
|
Curr Stem Cell Res Ther
|
2010
|
0.81
|
|
24
|
Modeling human liver biology using stem cell-derived hepatocytes.
|
Int J Mol Sci
|
2013
|
0.80
|
|
25
|
Maintaining hepatic stem cell gene expression on biological and synthetic substrata.
|
Biores Open Access
|
2012
|
0.80
|
|
26
|
Stem cell differentiation and human liver disease.
|
World J Gastroenterol
|
2012
|
0.79
|
|
27
|
Serum-Free Directed Differentiation of Human Embryonic Stem Cells to Hepatocytes.
|
Methods Mol Biol
|
2015
|
0.79
|
|
28
|
Novel biopolymers to enhance endothelialisation of intra-vascular devices.
|
Adv Healthc Mater
|
2012
|
0.78
|
|
29
|
Portal venous endothelium in developing human liver contains haematopoietic and epithelial progenitor cells.
|
Exp Cell Res
|
2010
|
0.77
|
|
30
|
Side population cells in developing human liver are primarily haematopoietic progenitor cells.
|
Exp Cell Res
|
2009
|
0.77
|
|
31
|
The complexities of engineering human stem cell-derived therapeutics.
|
J Biomed Biotechnol
|
2011
|
0.75
|